![Zhang Xiuping](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhang Xiuping
Direttore/Membro del Consiglio presso BIOSENSORS INTERNATIONAL GROUP LTD
Profilo
Ms. Zhang Xiuping is Independent Non-Executive Director at Biosensors International Group Ltd.
and a Managing Director at Moelis & Co. Asia Ltd.
She is on the Board of Directors at Biosensors International Group Ltd.
She received her MBA from Rollins College (Florida).
Posizioni attive di Zhang Xiuping
Società | Posizione | Inizio |
---|---|---|
BIOSENSORS INTERNATIONAL GROUP LTD | Direttore/Membro del Consiglio | 17/10/2014 |
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Amministratore Delegato | 27/09/2013 |
Formazione di Zhang Xiuping
Rollins College (Florida) | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Finance |
Biosensors International Group Ltd.
![]() Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Zhang Xiuping